Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers will conduct a seven-year study and develop an updated archive of data on alcohol and liver health.
In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.
Lockdowns made people feel isolated, depressed, and anxious, leading some to increase their alcohol intake.
Restoration of gut function and microbial diversity could lead to improvement of hepatic encephalopathy.
While hepatitis C remains a leading cause, cirrhosis is increasingly caused by fatty liver disease and alcohol use.
The tool helped decrease binge drinking episodes among Latino participants.
People who used cholesterol-lowering medications had a 40% lower risk for liver disease progression.
Researchers suggest cannabis use alone should not be a reason to deny transplants.
Better results were observed even in people with increased portal hypertension.
Experts predict that more than a million people could die from liver cancer worldwide in 2040.
Women and young adults saw especially large increases between 2019 and 2021.
Current guidelines recommend antiviral treatment regardless of alcohol use.
Black people make up only 6% and Latino people make up 5% of participants in cirrhosis trials in the United States.
Diabetes and a large waist circumference are predictors of liver fat accumulation and fibrosis.
Liver cancer is now less likely to be caused by hepatitis B or C, but more likely to be caused by fatty liver disease or alcohol.
Heavy alcohol use among people with hepatitis B or C increased the risk of liver cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.